We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"... selpercatinib in patients with stage IBIIIA RET fusionpositive nonsmall cell lung cancer (NSCLC) (Abstract LBA3). Lymphoma · The ASCO Post Staff ..."
"On the oncology front, Eli Lilly showcased the strength of Retevmo (selpercatinib) at the ASCO 2026 congress. The phase 3 LIBRETTO-432 study ..."
"Abstract. Background Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy with limited therapeutic options in advanced disease. While ..."
"Introduction. The current AJCC medullary thyroid cancer (MTC) staging system anatomically stratifies lymph node (LN) status but does not incorporate ..."
"To date, investigations of rearranged during transfection (RET) gene fusions and the use of the selective RET inhibitors selpercatinib (Retevmo) ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.